CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and animals.

The sequence contained a promising new genetic tool for modifying DNA, a CRISPR. Editas Medicine, a Massachusetts-based ...

Where some saw an imperfect compromise, other attendees apparently left the talks in disgust. In published reports, for ...

Research funded by the federal government has found useful expression in many of the defining technologies of our time. This ...

GenAssist’s IND application for GEN6050X receives US FDA clearance, a globally first-in-class base editing drug for duchenne muscular dystrophy: Suzhou, China Friday, March 7, 2 ...

Market OverviewGlobal Genotyping Assay Market is valued at USD 14.36 Billion in 2022 and is projected to attain a value of ...

The "AAV Vectors in Gene Therapy - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.The Adeno-Associated Virus (AAV) Vectors in Gene Therapy pipeline signifies a ...

AbbVie made a $350 million upfront payment to Gubra for rights to the drug, called GUB014295. Gubra is also eligible to receive another $1.9 billion if certain development and sales milestones are met ...

In Alzheimer's disease, certain proteins accumulate in brain cells, forming clumps that restrict normal cell function or even ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...

SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small-molecule biosynthetic compounds for the treatment ...